🇺🇸 FDA
Pipeline program

Amiodarone hydrochloride 200 mg tablets

IIBSP-AMI-2024-33

Approved small_molecule active

Quick answer

Amiodarone hydrochloride 200 mg tablets for Persistent atrial fibrillation is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Persistent atrial fibrillation
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials